Nathan A Lack

18PUBLICATIONS
148CO-AUTHORS
Molecular targetsPredictive and prognostic markersPharmaceutical delivery technologiesGenome structure and regulationCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Apr 29, 2026
Evaluation of Tissue from Patients with Prostate Cancer Identifies B7-H3 as an Androgen-Regulated, Broadly-Expressed, Combinatorial Therapeutic Target.

|Dec 04, 2025
Distinct transcription factor interactions drive HOXB13 activity in different stages of prostate cancer.

Betul Ersoy-Fazlioglu, Shreyas Lingadahalli, Umut Berkay Altintas

|Oct 22, 2025
Baited SELEX: Drug-Directed Selection of Aptamers to PSMA for <i>In Vivo</i> Targeting of Prostate Cancer Xenografts in Mice.

Kun Liu, Nicole Robinson, Emirhan Tekoglu

|Oct 08, 2025
Elucidating molecularly stratified single agent, and combination, therapeutic strategies targeting MCL1 for lethal prostate cancer.

Juan M Jiménez-Vacas, Daniel Westaby, Ines Figueiredo

|Aug 20, 2025
Coregulators determine androgen receptor activity in prostate cancer.

Kerim Yavuz, Nathan A Lack

|Feb 05, 2025
Identification of selective SWI/SNF dependencies in enzalutamide-resistant prostate cancer.

Bengul Gokbayrak, Umut Berkay Altintas, Shreyas Lingadahalli

Pageof 3

Frequent Collaborators

4 joint publications

Tugba Bagci-Onder

4 joint publications

Umut Berkay Altıntaş

3 joint publications

Chia-Chi Flora Huang

3 joint publications

Wilbert Zwart